Trade Ideas

Actionable trade ideas with defined risk and time horizons.

Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.

Articles

7,239 total articles

Amdocs: A Low-Drama Telecom Software Play With Quiet AI Optionality

Amdocs: A Low-Drama Telecom Software Play With Quiet AI Optionality

Amdocs (DOX) looks ugly on the chart but fundamentally intact: $5.5B market cap, over $500m in free cash flow, mid-teens ROE, and a 4%-ish dividend yield. The stock is trading near its 52-week low with RSI in the low 20s — a technical oversold signal. Combine valuation (P/E ~11), steady cash flow, and real industry tailwinds around cloud OSS/BSS, 5…

Magnite: CTV Momentum Looks Set to Drive Re-rating — tactical long

Magnite: CTV Momentum Looks Set to Drive Re-rating — tactical long

Magnite's growing footprint in Connected TV (CTV) — highlighted by recent partnerships with JioHotstar, dentsu and Hearst — is shifting supply-side pricing power higher. With a $2.56B market cap, improving technicals and a reasonable P/E, this is a tactically attractive long for traders looking to capture multiple expansion and continued CTV moneti…

First Majestic: Cash Flow Is Turning; Price Isn’t — A Swing Trade Case

First Majestic: Cash Flow Is Turning; Price Isn’t — A Swing Trade Case

First Majestic (AG) is generating free cash flow again and its balance sheet looks manageable, yet the market has not rewarded the shares commensurately. This trade idea buys a near-term swing on improving cash flow, modest technical support, and optional upside from silver prices — with tight risk controls because valuation remains rich versus rep…

Rocket Lab: A Tactical Long After the SpaceX IPO - Here's the Trade Plan

Rocket Lab: A Tactical Long After the SpaceX IPO - Here's the Trade Plan

Rocket Lab (RKLB) is trading near $107 after a post-IPO sector rotation. The company's low leverage, strong liquidity metrics, and concentrated position in small-satellite launch and space systems give it a credible path to capture incremental demand created by SpaceX's recent IPO. Valuation is rich, but the technical setup and sector catalysts cre…

Buy DHX on Cash-Flow Strength: Cheap, Cash-Generating, and Undervalued

Buy DHX on Cash-Flow Strength: Cheap, Cash-Generating, and Undervalued

DHI Group (DHX) is a compact, cash-generative operator that looks inexpensive on free cash flow and enterprise multiples. With free cash flow of $20.47M, an EV/EBITDA of ~6.5x and a market cap near $164M, the stock offers asymmetric upside to $7 while downside is limited if fundamentals hold. Trade idea: opportunistic long with a clear stop and sta…

Cognizant at a Crossroads: Oversold, Cheap, and Worth a Tactical Long

Cognizant at a Crossroads: Oversold, Cheap, and Worth a Tactical Long

Cognizant (CTSH) has tumbled to near its 52-week low, trading at single-digit multiples, strong free cash flow and very low net leverage. Technicals are oversold and short interest is elevated, which creates a tactical long setup with defined risk. This trade idea lays out entry, stop and target levels, the investment thesis, valuation context, cat…

Xometry After the Rally - Why I'm Still Buying and Where I Draw the Line

Xometry After the Rally - Why I'm Still Buying and Where I Draw the Line

Xometry's AI-driven industrial marketplace has ripped higher, but the fundamental picture still supports more upside: accelerating revenue, improving profitability signals, a successful $225M equity raise at $85, and a materially reduced short interest backdrop. This trade idea lays out an exact entry, stop, and target, the time horizon for the tra…

SmartRent at the Bargain Bin: Tactical Long After a Downgrade

SmartRent at the Bargain Bin: Tactical Long After a Downgrade

SmartRent (SMRT) looks unusually cheap on headline metrics - market cap near $220M, EV roughly $119M and EV/Sales ~0.8 - but the stock still carries execution, cash-flow and legal overhangs. We lower the rating on fundamentals and governance risk, yet present a tactical swing trade: a small, structured long at $1.14 with a tight stop and a target n…

Buy Alphabet on Cloud Momentum and AI Capex Optionality

Buy Alphabet on Cloud Momentum and AI Capex Optionality

Alphabet ($GOOG) is a conviction long over the next 180 trading days. Google Cloud’s stronger-than-expected commercial traction, combined with Alphabet’s $64.4B free cash flow and low leverage, supports further AI infrastructure investment that can re-accelerate revenue and margins. Enter near $368.00, stop $346.00, target $405.00.

New Found Gold: Buy the Pullback — High-Grade Asset, Reasonable Valuation, Weathering Stable Gold Prices

New Found Gold: Buy the Pullback — High-Grade Asset, Reasonable Valuation, Weathering Stable Gold Prices

New Found Gold (NFGC) is a development-stage gold producer sitting on high-grade Newfoundland assets. At a market cap near $568M, the stock is priced for execution rather than speculation. Technicals show a short-term oversold tone while fundamentals — recent drill success and rising industry M&A — support upside if management continues to advance …

How to Get in Early on Sivers Semiconductors: A 180-Day Trade Plan

How to Get in Early on Sivers Semiconductors: A 180-Day Trade Plan

Sivers Semiconductors (SIVR) is an underfollowed RF and mmWave component specialist positioned to benefit from a renewed 5G infrastructure refresh and edge connectivity builds. This trade idea lays out a precise entry at $2.40, a protective stop at $1.60 and a $4.20 target over a 180 trading day horizon, with clear catalysts and risks.

KBR: Hidden SOTP Upside — Buy the Re-rate in Defense + Sustainability

KBR: Hidden SOTP Upside — Buy the Re-rate in Defense + Sustainability

KBR trades at ~10x 2026 EPS with $489M in free cash flow and a $6.36B enterprise value that looks cheap relative to the optionality in its Mission Technology and Sustainable Technology franchises. A disciplined entry around current levels with a tight stop and a 180-trading-day target captures both contract ramp and a potential re-rating tied to co…

XDEMVY Is Carrying Tarsus — Pay Up, But Don’t Pay Blindly

XDEMVY Is Carrying Tarsus — Pay Up, But Don’t Pay Blindly

Tarsus has turned its FDA approval into real revenue: XDEMVY generated strong top-line growth and margin leverage in early 2026. The stock is not cheap on traditional multiples, but guidance for $670-700M in XDEMVY sales for 2026 narrows the gap between price and prospective value. This trade idea buys the story on continued execution while protect…